Profile: Trevigen, Inc. is a biotechnology company focused on the development of products & technology for cancer research, emphasizing apoptosis, DNA damage & repair, and cancer cell function & behavior. We offer apoptosis detection kits, directed in vivo angiogenesis assay, DNA repair enzymes, antibodies, and kits to detect DNA damage. We also offer high throughput screening formats for investigating superoxide dismutase, glutathione & its derivatives, 8 oxo dG, and nitric oxide conveniently provided for 96 well analysis.